The Effect of Memantine on Aggression and Agitation and Its Impact on Caregiver Burden of Patients With Alzheimer's Disease: A 12-week Open-label Study
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Memantine (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- 24 Jan 2013 Planned end date changed from 1 Jun 2009 to 1 Jun 2014 as reported by ClinicalTrials.gov.
- 16 Jul 2008 New trial record.